Sanofi ADR (SNY)

45.87 +0.33 (+0.72%)
Real-time Cboe USD Disclaimer

SNY Financial Summary

Sanofi reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was EUR 12,482 million compared to EUR 10,432 million a year ago. Net income was EUR 2,076 million compared to EUR 2,310 million a year ago. Basic earnings per share from continuing operations was EUR 1.66 compared to EUR 1.84 a year ago.For the nine months, sales was EUR 32,272 million compared to EUR 27,767 million a year ago. Net income was EUR 5,260 million compared to EUR 5,074 million a year ago. Basic earnings per share from continuing operations was EUR 4.2 compared to EUR 4.05 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
SNY
Gross margin TTM 69.71%
Operating margin TTM 23.98%
Net Profit margin TTM 14.45%
Return on Investment TTM 10.18%
Total Revenue
Net Income
Title
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Total Revenue 13,138 10,742 10,053
Gross Profit 9,307 7,492 7,173
Operating Income 4,652 1,980 2,573
Net Income 2,076 1,175 2,009
Clear All
0Selected
Please try another search
SNY
Quick Ratio MRQ 0.67
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 29.93%
Total Assets
Total Liabilities
Title
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Total Assets 121,826 120,242
Total Liabilities 50,522 51,211
Total Equity 71,304 68,681
Clear All
0Selected
Please try another search
SNY
Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow -
Cash
Net Change in Cash
Title
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Cash From Operating Activities 10,522
Cash From Investing Activities -7,298
Cash From Financing Activities -7,056
Net Change in Cash -3,817
Clear All
0Selected
Please try another search

* In Millions of EUR (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles